SCHEMBL8096722

SCHEMBL8096722

CCOc1ccc(-c2cn3c(=O)[nH]c4c(c3n2)CCCC4)cc1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 7/20 0.53
GABRA2 P47869 7/20 0.53
GABRA3 P34903 4/20 0.48
GABRA5 P31644 2/20 0.48
CDKN1A P38936 1/20 0.44
ADORA2A P29274 1/20 0.43
MAPT P10636 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
POLB P06746 1/20 0.42
HPGD P15428 1/20 0.42
CRHBP P24387 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
CRHR2 Q13324 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8097270 0.88 GABRA1 (0.63) GABRA1GABRA2GABRA3GABRA5MAPT
SCHEMBL8097290 0.86 GABRA1 (0.54) GABRA1GABRA2GABRA3GABRA5
SCHEMBL8088161 0.84 GABRA1 (0.61) GABRA1GABRA2GABRA3GABRA5SMN1; SMN2
SCHEMBL8096721 0.82 GABRA2 (0.53) GABRA1GABRA2GABRA3GABRA5MAPT
SCHEMBL8094738 0.82 GABRA2 (0.61) GABRA1GABRA2GABRA3GABRA5
SCHEMBL8094714 0.81 GABRA2 (0.64) GABRA1GABRA2GABRA3GABRA5
SCHEMBL8101160 0.77 GABRA1 (0.55) GABRA1GABRA2GABRA3GABRA5
SCHEMBL8096416 0.77 GABRA1 (0.67) GABRA1GABRA2GABRA3GABRA5ADORA2A
SCHEMBL8101242 0.76 GABRA1 (0.50) GABRA1GABRA2GABRA3GABRA5
SCHEMBL8087778 0.75 GABRA2 (0.46) GABRA1GABRA2GABRA3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5426186-A Diagnosis, treatment of anxiety, sleep and seizure disorders, benzodiazepine overdose; enhancement of alertness NEUROGEN CORPORATION (US) 1995-06-20 US claimed
US-6013799-A HIGHLY SELECTIVE AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR G-AMINOBUTYRIC ACID (GABA) BRAIN RECEPTORS; USEFUL IN DIAGNOSIS/TREATMENT OF ANXIETY, SLEEP, AND SEIZURE DISORDERS, DRUG OVERDOSE, AND ALERTNESS ENHANCEMENT ALERTNESS NEUROGEN CORPORATION (US) 2000-01-11 US disclosed
US-5696260-A AGONSIT, ANTAGONIST, PRODRUG; USEFUL IN DIAGNOSIS AND TREATMENT OF ANXIETY, SLEEP, SEIZURE DISORDER, OVERDOSE WITH BENZODIAZEPINE TYPE DRUGS AND ENHANCEMENT OF ALERTNESS NEUROGEN CORPORATION (US) 1997-12-09 US disclosed
US-5426186-A Diagnosis, treatment of anxiety, sleep and seizure disorders, benzodiazepine overdose; enhancement of alertness NEUROGEN CORPORATION (US) 1995-06-20 US disclosed